TY - JOUR
T1 - Carotenoids, vitamin A, and estrogen receptorstatus in breast cancer
AU - Rock, Cheryl L.
AU - Saxe, Gordon A.
AU - Ruffin IV, Mack T.
AU - August, David A.
AU - Schottenfeld, David
N1 - Funding Information:
The authors thank Dr. Hemmige Bhagavan of Hoffmann-La Roche (Nutley, NJ) for supplying the internal standard for carotenoid determinations; Drs. Lynne Carpenter, Allen Lichter, and Harold Oberman, and the staff of the University of Michigan Breast Care Center; Dana Randall, Cathryn Carter, Robin Kusluski, M. Matilda Galvez, and Emily Maimon for technical assistance; Drs. Daniel Gorenflo and Michael A. Schork for assistance with data analysis; and Dr. Max Wicha for guidance and support. This study was supported in part by an award from the Breast Care Center, University of Michigan Comprehensive Cancer Center. M. T. Ruffin IV was supported by Preventive Oncology Academic Award K7-CA-01618-03 from the National Cancer Institute (Bethesda, MD). Address reprint requests to Dr. Cheryl Rock, M5539 SPHII, Human Nutrition Program, University of Michigan, Ann Arbor, MI 48109-2029.
PY - 1996
Y1 - 1996
N2 - Among patients with breast cancer, tumors that contain estrogen receptors (ER) are associated with improved survival and better response to hormone therapy than those not expressing these receptors. The purpose of these case comparison studies was to examine the relationship between carotenoids, vitamin A, and the tumor ER status in women at diagnosis of primary breast cancer. The focus of the first study was the relationship between dietary intake and ER status, and the focus of the second study was the relationship between ER status and the plasma carotenoid, retinol, and tocopherol concentrations. We evaluated tumor ER status and self-reported dietary intake in 142 women and plasma concentrations of carotenoids, retinol, and tocopherols in 149 women, at diagnosis of breast cancer, before any medical or surgical treatment. In the first study the overall odds of ER-positive status were increased in relation to number of mammograms in the past five years, number of breast-fed babies, dietary carotenoid intake, and more frequent intake of yellow and green vegetables. Overall odds of ER-positive status were decreased in relation to years of oral contraceptive use and preformed vitamin A intake. In the second study older women, women with higher plasma lutein concentration, and women not using β-carotene supplements were more likely to be ER positive, when data were adjusted for body mass index and factors that may influence breast cancer risk or hormonal status. Significant independent relationships between plasma retinal or tocopherol concentrations and ER status were not observed. The strong and independent relationships between carotenoid intake, plasma lutein concentration, and ER status may relate to observations linking a carotenoid-rich diet with improved prognosis after diagnosis of breast cancer.
AB - Among patients with breast cancer, tumors that contain estrogen receptors (ER) are associated with improved survival and better response to hormone therapy than those not expressing these receptors. The purpose of these case comparison studies was to examine the relationship between carotenoids, vitamin A, and the tumor ER status in women at diagnosis of primary breast cancer. The focus of the first study was the relationship between dietary intake and ER status, and the focus of the second study was the relationship between ER status and the plasma carotenoid, retinol, and tocopherol concentrations. We evaluated tumor ER status and self-reported dietary intake in 142 women and plasma concentrations of carotenoids, retinol, and tocopherols in 149 women, at diagnosis of breast cancer, before any medical or surgical treatment. In the first study the overall odds of ER-positive status were increased in relation to number of mammograms in the past five years, number of breast-fed babies, dietary carotenoid intake, and more frequent intake of yellow and green vegetables. Overall odds of ER-positive status were decreased in relation to years of oral contraceptive use and preformed vitamin A intake. In the second study older women, women with higher plasma lutein concentration, and women not using β-carotene supplements were more likely to be ER positive, when data were adjusted for body mass index and factors that may influence breast cancer risk or hormonal status. Significant independent relationships between plasma retinal or tocopherol concentrations and ER status were not observed. The strong and independent relationships between carotenoid intake, plasma lutein concentration, and ER status may relate to observations linking a carotenoid-rich diet with improved prognosis after diagnosis of breast cancer.
UR - http://www.scopus.com/inward/record.url?scp=0029938108&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029938108&partnerID=8YFLogxK
U2 - 10.1080/01635589609514452
DO - 10.1080/01635589609514452
M3 - Article
C2 - 8771571
AN - SCOPUS:0029938108
VL - 25
SP - 281
EP - 296
JO - Nutrition and Cancer
JF - Nutrition and Cancer
SN - 0163-5581
IS - 3
ER -